These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37068267)

  • 41. Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases.
    Sakamoto AP; Pinheiro MM; Barbosa CM; Fraga MM; Len CA; Terreri MT
    Rev Bras Reumatol; 2015; 55(6):536-41. PubMed ID: 26066294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic Arthritis.
    Luca NJ; Burnett HF; Ungar WJ; Moretti ME; Beukelman T; Feldman BM; Schwartz G; Bayoumi AM
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1803-1811. PubMed ID: 27059807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
    Batthish M; Berard R; Cabral D; Bolaria R; Chédeville G; Duffy C; Gerhold K; Gerschman T; Huber A; Proulx-Gauthier JP; Rosenberg A; Rumsey D; Schmeling H; Shiff N; Soon G; Bruns A; Tucker L; Guzman J;
    Rheumatology (Oxford); 2020 Oct; 59(10):2796-2805. PubMed ID: 32044978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Features and Clinical Course of Infantile Juvenile Idiopathic Arthritis.
    Campbell JA; Shenoi S
    J Clin Rheumatol; 2022 Mar; 28(2):e609-e611. PubMed ID: 33843769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study.
    Felis-Giemza A; Chmurzyńska K; Kołodziejczyk B; Gazda A
    Rheumatol Int; 2023 Jul; 43(7):1307-1311. PubMed ID: 36859560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis.
    Kip MMA; de Roock S; Currie G; Marshall DA; Grazziotin LR; Twilt M; Yeung RSM; Benseler SM; Vastert SJ; Wulffraat N; Swart JF; IJzerman MJ
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI170-SI180. PubMed ID: 35583252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.
    Tynjälä P; Lahdenne P; Vähäsalo P; Kautiainen H; Honkanen V
    Ann Rheum Dis; 2006 Aug; 65(8):1044-9. PubMed ID: 16449314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Klotsche J; Niewerth M; Haas JP; Huppertz HI; Zink A; Horneff G; Minden K
    Ann Rheum Dis; 2016 May; 75(5):855-61. PubMed ID: 25926155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis.
    Kuemmerle-Deschner JB; Horneff G
    Rheumatol Int; 2007 Dec; 28(2):153-6. PubMed ID: 17641897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of paediatric and adult classification criteria in juvenile idiopathic arthritis during the transition from paediatric to adult care.
    Debrach AC; Rougelot A; Beaumel A; Cabrera N; Belot A; Duquesne A; Aubry-Rozier B; Hofer M; Couret M; Larbre JP; Coury F
    Joint Bone Spine; 2021 Jan; 88(1):105047. PubMed ID: 32653654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
    Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
    Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt.
    Mourão AF; Santos MJ; Melo Gomes JA; Martins FM; Mendonça SC; Oliveira Ramos F; Fernandes S; Salgado M; Guedes M; Carvalho S; Costa JA; Brito I; Duarte C; Furtado C; Lopes A; Rodrigues A; Sequeira G; Branco JC; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2016 Apr; 55(4):697-703. PubMed ID: 26672905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors.
    Walters HM; Pan N; Lehman TJ; Adams A; Huang WT; Sitaras L; Cunningham-Rundles S; Walsh TJ; Toussi SS
    Clin Rheumatol; 2015 Mar; 34(3):457-64. PubMed ID: 25227771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA).
    Nassar-Sheikh Rashid A; Schonenberg-Meinema D; Bergkamp SC; Bakhlakh S; de Vries A; Rispens T; Kuijpers TW; Wolbink G; van den Berg JM
    Pediatr Rheumatol Online J; 2021 Apr; 19(1):59. PubMed ID: 33926495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
    Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Switched Memory B Cells Are Increased in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis and Their Change Over Time Is Related to Response to Tumor Necrosis Factor Inhibitors.
    Marasco E; Aquilani A; Cascioli S; Moneta GM; Caiello I; Farroni C; Giorda E; D'Oria V; Marafon DP; Magni-Manzoni S; Carsetti R; De Benedetti F
    Arthritis Rheumatol; 2018 Apr; 70(4):606-615. PubMed ID: 29316374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
    Otten MH; Anink J; Spronk S; van Suijlekom-Smit LW
    Ann Rheum Dis; 2013 Nov; 72(11):1806-12. PubMed ID: 23172748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
    Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
    Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.